| Ghrelin, n = 10 | Placebo, n = 10 | Treatment effect (95% CI; p value†) | ||
---|---|---|---|---|---|
 | Pre-treatment | Mean D. | Pre-treatment | Mean D. |  |
| 13.2 (3.7) | 0.5 (1.8) | 13.4 (3.2) | -0.8 (1.1) | 1.2 (-0.2 to 2.6; 0.085) |
Dyspnea (Borg) | 7.2 (1.5) | -2.0 (2.6)* | 7.0 (1.7) | -2.7 (3.2)* | 0.7 (-2.1 to 3.4; 0.606) |
Leg discomfort (Borg) | 5.4 (2.7) | -1.9 (2.9) | 6.2 (2.6) | -3.0 (2.9)* | 1.1 (-1.6 to 3.9; 0.399) |
VT (L) | 0.97 (0.16) | 0.10 (0.08)** | 1.06 (0.12) | 0.09 (0.24) | 0.01 (-0.15 to 0.18; 0.876) |
f (breaths/min) | 34 (7) | -4 (6)* | 28 (5) | -3 (8) | -1 (-8 to 5; 0.658) |
| 31.8 (6.1) | -0.4 (4.6) | 29.2 (6.5) | -1.6 (3.6) | 1.2 (-2.6 to 5.1; 0.510) |
VD/VT | 0.39 (0.06) | -0.03 (0.04)* | 0.36 (0.05) | 0.01 (0.04) | -0.04 (-0.08 to -0.00; 0.048) |
| 52.5 (12.7) | -3.3 (3.6)* | 47.9 (7.2) | 0.2 (4.9) | -3.5 (-7.6 to 0.5; 0.086) |
| 51.1 (13.7) | -2.7 (5.3) | 45.2 (7.5) | 0.9 (5.2) | -3.6 (-8.6 to 1.4; 0.149) |
Pao2 (mmHg) | 64.5 (16.0) | 1.0 (5.4) | 66.2 (11.8) | -1.1 (4.8) | 2.1 (-2.7 to 7.0; 0.361) |
Paco2 (mmHg) | 42.6 (6.9) | -1.1 (2.4) | 42.4 (4.2) | 0.0 (3.1) | -1.2 (-3.8 to 1.4; 0.359) |
HR (beats/min) | 118 (14) | -2 (9) | 113 (13) | 2 (6) | -4 (-11 to 4; 0.290) |
| 5.4 (1.5) | 0.2 (0.8) | 5.5 (1.1) | -0.3 (0.4)* | 0.5 (-0.1 to 1.1; 0.093) |
Plasma LT (mg/dL) | 32.1 (11.8) | -0.3 (8.3) | 34.9 (14.6) | -3.5 (7.9) | 3.2 (-4.4 to 10.8; 0.920) |
Plasma NE (ng/mL) | 2.44 (1.71) | -0.37 (1.40) | 2.64 (1.81) | -0.77 (1.06)* | 0.40 (-0.77 to 1.56; 0.426) |